Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Abroad (travel likely)RecruitingPHASE2

Conditions

Food Hypersensitivity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins, Baltimore, Maryland, United States
Contact: Study coordinator (Robert+ Wood, MD) · pediatricallegy@JHMI.edu · 410-955-5883
Contact: Study coordinator (Kim Mudd, RN) · kmudd2@jhmi.edu · 410-502-1711

Study leads

Robert Wood, MD
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity

Food Allergy · Food Hypersensitivity

Abroad (travel likely)Recruiting

Erlangen, Germany

Omalizumab Weight-Based Dosing Efficacy Trial

Allergies · Food Allergy

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Chapel Hill, United States